Back to Search Start Over

Trastuzumab Deruxtecan in Human Epidermal Growth Factor Receptor 2–Expressing Biliary Tract Cancer (HERB; NCCH1805): A Multicenter, Single-Arm, Phase II Trial.

Details

Language :
English
ISSN :
0732183X
Volume :
42
Issue :
27
Database :
Supplemental Index
Journal :
Journal of Clinical Oncology
Publication Type :
Academic Journal
Accession number :
179689158
Full Text :
https://doi.org/10.1200/JCO.23.02010